Module Specifications..
Current Academic Year 2023 - 2024
Please note that this information is subject to change.
| |||||||||||||||||||||||||||||||||||||||||||||||||||
None |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Description Module aims: The purpose of this module is to provide a detailed understanding of the innate and adaptive immune systems in protecting the host against pathogens and microorganisms. Students will subsequently learn how the immune system can be manipulated for disease recognition, particularly in relation to vaccine production and cancer. The module will also provide a comprehensive overview of the production, manipulation and purification of antibodies for diagnostic, biomedical and therapeutic applications. | |||||||||||||||||||||||||||||||||||||||||||||||||||
Learning Outcomes 1. Compare and contrast the cells and components of the innate and adaptive immune systems. 2. Describe how the immune system and immune responses have been exploited for the development of vaccines and cancer. 3. Describe in detail the methods used to produce antibodies and antibody fragments in the laboratory. 4. Identify applications of antibodies and antibody fragments for research, diagnostic and therapeutic applications. 5. Describe several different types of immunoassays and select the most appropriate immunoassay to detect/quantify a particular antigen. 6. Discuss how antibody-based therapy can be used to treat human disease. | |||||||||||||||||||||||||||||||||||||||||||||||||||
All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Indicative Content and Learning Activities
Fundamental and Translational ImmunologyThe Innate Immune System; The Adaptive Immune System - T-cells; T-cell therapies; CAR T-cells; The Adaptive Immune System - B-cells; Vaccines; Antibody Production; Antibodies and Immunoassays; Therapeutic Antibodies Part 1; Therapeutic Antibodies Part 2. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Indicative Reading List
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Other Resources None | |||||||||||||||||||||||||||||||||||||||||||||||||||
Programme or List of Programmes
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Archives: |
|